Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization
Lacosamide
SP754
NCT00136019
Epilepsy
Phase 3
 
Analysis and Reporting Dataset is AD not ADaM

Datasets are available in English only
July 2014

Powered by ideaPoint, Inc.